SteveSommerMD

PubMed

• 56 citations
  Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.
  Margaret V. Ragni, Oluseyi Ojeifo, Jinong Feng, Jin Yan, Kathleen A. Hill
  Haemophilia. 2009-09-01
• 24 citations
  Pyrophosphorolysis-activatable oligonucleotides may facilitate detection of rare alleles, mutation scanning and analysis of chromatin structures.
  Qiang Liu, Steve S. Sommer
  Nucleic Acids Research. 2002-01-15
• 2 citations
  Microarray-based DNA resequencing using 3' blocked primers.
  Jakub Sram, Steve S. Sommer, Qiang Liu
  Analytical Biochemistry. 2008-03-01

Journal Articles

• Quantitative in-vivo evaluation of translational bypass therapy of nonsense mutations: Geneticin generates a dramatic multi-day response  
  Chunmei, Y., Feng, J., Song, W, Wang, J.C., Tsai, B., Zhang, Y., Hill, K.A., High, K., Sommer, S.S., PNAS, 1/1/2009
• Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer  
  Chen, Z., Feng, J., Buzin, C.H., Liu, Q., Weiss, L., Kernstine, K., Somlo, G., Sommer, S.S., PLoS One, 1/1/2009
• Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations  
  Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C.H., Longmate, J., Heston, L.L., Rossi, J., Sommer, S.S., PLoS One, 1/1/2009
• Human Somatic Microindels  
  Scaringe, W.A., Li, K., Gu, D., Chen, Z, Gonzalez, Kelly D., Hill, K., Sommer, S.S., Human Molecular Genetics, 1/1/2008
• High Risk Cohort-specific Variants in DISC1 are Identified and Associated with Schizophrenia with an Estimated Attributable Risk of 2%  
  Song, W., Li, W., Heston, L.L., Scaringe, W.A., Feng, J., Sommer, S.S., Biochemical and Biophysical Research Communications, 1/1/2008
• Evidence for Mutation Showers  
  Wang, J., Gonzalez, K.D., Scaringe, W.A., Tsai, K., Liu, N., Gu, D., Li, W., Hill, K.A., Steve S. Sommer, PNAS, 1/1/2007
• A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin  
  Yang, C., Feng, J., Song, W., Wang, J.C., Tsai, B., Zhang, Y., Scaringe, W., Hill, K.A., Margaritis, P., High, K., Sommer, S.S., PNAS, 1/1/2007
• High Frequency of Neurexin 1b Signal Peptide Structural Variants in Patients with Autism  
  Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E.H., Jr., Skinner, C., Schwartz, C., Sommer, S.S., Neuroscience Letters, 1/1/2006
• Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients  
  Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., Sram, J., Bockholt, A., Jones, I.R., Craddock, N., Cook, E.H. Jr., Vicente, A., Sommer, S.S., Molecular Psychiatry, 1/1/2005
• PAP: Detection of ultra-rare mutations depends on P* oligonucleotides, “sleeping beauties” awakened by the kiss of pyrophosphorolysis  
  Liu, Q., Sommer, S.S., Human Mutations, 1/1/2004
• Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value  
  Kovach, J.S., Hartmann, A., Blaszyk, H., Cunningham, J., Schaid, D., and Sommer, S.S., Proc. National Academy of Science USA, 1/1/1996
• Evidence for diverse mutagens in breast cancer-  
  Blaszyk, H., Hartmann, A., Liao, D-z., Kovach, J.S., and Sommer, S.S., Lancet, 1/1/1996
• Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and pattern of p53 gene mutations differ among these two low-risk p...  
  Blaszyk, H., Hartmann, A., Tamura, Y., Saitoh, S., Cunningham, J.M., McGovern, R.M., Schroeder, J.J., Schaid, D.J., Ii, K., Monden, Y., Morimoto, T., Komaki, K., Sasa,..., Oncogene, 1/1/1996
• p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain  
  Nishino, H., Knoll, A., Buettner, V.L., Frisk, C.S., Maruta, Y., Haavik, J., and Sommer, S.S., Oncogene, 1/1/1995
• p53 gene mutations in breast cancers in Midwestern US women: null as well as missense-type mutations are associated with poor prognosis  
  Saitoh, S., Cunningham, J., DeVries, E.M.G., McGovern, R.M., Schroeder, J.J., Hartmann, A., Blaszyk, H., Schaid, D., Sommer, S.S., and Kovach, J.S., Oncogene, 1/1/1994
• Genotype relative risks: methods for design and analysis of candidate-gene association studies  
  Schaid, D.J., and Sommer, S.S., American Journal of Human Genetics, 1/1/1993
• Delineation of genetic predisposition to multifactorial disease: A general approach on the threshold of feasibility  
  Sobell, J.L., Heston, L., and Sommer, S.S., Genomics, 1/1/1992
• Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germline transitions, transversions, and deletions in a human gene  
  Koeberl, D.D., Bottema, C.D.K., Ketterling, R.P., Bridges, P.J., Lillicrap, D.P., and Sommer, S.S., Am. J. Hum. Genet., 1/1/1990
• Mutagen test  
  Sommer, S.S., Nature, 1/1/1990
• Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germline transitions, transversions, and deletions in a human gene  
  Koeberl, D.D., Bottema, C.D.K., Ketterling, R.P., Bridges, P.J., Lillicrap, D.P., and Sommer, S.S., American Journal of Human Genetics, 1/1/1990
• Shedding light on PCR contamination  
  Sarkar, G., and Sommer, S.S., Nature, 1/1/1990
• Direct carrier testing in 14 families with hemophilia B  
  Bottema, C.D.K., Koeberl, D.D., and Sommer, S.S., The Lancet, 1/1/1989
• Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity  
  Sarkar, G., and Sommer, S.S., Science, 1/1/1989
• Genomic amplification with transcript sequencing  
  Stoflet, E.S., Koeberl, D.D., Sarkar, G. and Sommer, S.S., Science, 1/1/1988
• Join now to see all